Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine

BACKGROUND: The mRNA vaccines help protect from COVID-19 severity, however multiple sclerosis (MS) disease modifying therapies (DMTs) might affect the development of humoral and T-cell specific response to vaccination. METHODS: The aim of the study was to evaluate humoral and specific T-cell respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Dominelli, Federica, Zingaropoli, Maria Antonella, Tartaglia, Matteo, Tortellini, Eeva, Guardiani, Mariasilvia, Perri, Valentina, Pasculli, Patrizia, Ciccone, Federica, Malimpensa, Leonardo, Baione, Viola, Napoli, Anna, Gaeta, Aurelia, Lichtner, Miriam, Conte, Antonella, Mastroianni, Claudio Maria, Ciardi, Maria Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753571/
https://www.ncbi.nlm.nih.gov/pubmed/36532061
http://dx.doi.org/10.3389/fimmu.2022.1050183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753571/
https://www.ncbi.nlm.nih.gov/pubmed/36532061
http://dx.doi.org/10.3389/fimmu.2022.1050183

Ejemplares similares